These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarction. Kluft C; Munkvad S; Gram J; Jespersen J Agents Actions Suppl; 1992; 38 ( Pt 2)():299-304. PubMed ID: 1462835 [No Abstract] [Full Text] [Related]
3. [Thrombolytic treatment of acute myocardial infarct. 1]. Soares-Costa JT; Soares-Costa TJ; Gabriel HM Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051 [TBL] [Abstract][Full Text] [Related]
4. [Tissue plasminogen activator is the best thrombolytic agent]. Bates E Arq Bras Cardiol; 1994 Jul; 63(1):57-8. PubMed ID: 7857215 [No Abstract] [Full Text] [Related]
5. [Thrombolytic therapy of acute myocardial infarction]. Chen JL Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):69-70. PubMed ID: 15808085 [No Abstract] [Full Text] [Related]
7. Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist. Vogel JH Clin Cardiol; 1991 Jul; 14(7):548. PubMed ID: 1810292 [No Abstract] [Full Text] [Related]
8. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations]. Roguin A; Manaster J; Roguin N Harefuah; 1993 Jun; 124(12):770-5. PubMed ID: 8375772 [No Abstract] [Full Text] [Related]
9. [Experience with the thrombolytic therapy of myocardial infarct]. Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835 [No Abstract] [Full Text] [Related]
10. Thrombolysis utilisation in acute myocardial infarction in Bahrain. Chawla AK; Nambiar CA; Murad AA Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556 [TBL] [Abstract][Full Text] [Related]
11. Second-dose thrombolytic following myocardial infarction. Furniss SS; Millar RN; Commerford PJ S Afr Med J; 1997 Feb; 87(2):179, 182. PubMed ID: 9107231 [No Abstract] [Full Text] [Related]
12. Thrombolytic therapy for myocardial infarction. Guerci AD Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282 [TBL] [Abstract][Full Text] [Related]
13. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?]. Negrini M G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921 [No Abstract] [Full Text] [Related]
14. [Thrombolytic therapy for myocardial infarction in oral anticoagulation]. Pizzulli L; Lüderitz B Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737 [No Abstract] [Full Text] [Related]
15. Role of the nurse in thrombolytic therapy. Albarran J; Kapeluch H Br J Nurs; 1994 Feb 10-23; 3(3):104-9. PubMed ID: 8148624 [TBL] [Abstract][Full Text] [Related]
17. [The Medical Products Agency and thrombolytic therapy in acute myocardial infarction]. Rasmussen K Tidsskr Nor Laegeforen; 1994 Jun; 114(17):2033-4. PubMed ID: 8079341 [No Abstract] [Full Text] [Related]
18. Is the use of t-PA as compared with streptokinase cost effective? Armentano R; Favaloro RG N Engl J Med; 1995 Oct; 333(15):1009-10. PubMed ID: 7666905 [No Abstract] [Full Text] [Related]
19. [Thrombolytic therapy of acute myocardial infarction]. Chen HZ Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):5-6. PubMed ID: 8404321 [No Abstract] [Full Text] [Related]
20. Is the use of t-PA as compared with streptokinase cost effective? Rose EA N Engl J Med; 1995 Oct; 333(15):1009; author reply 1010. PubMed ID: 7666904 [No Abstract] [Full Text] [Related] [Next] [New Search]